Clinical utility of urinary soluble Fas in screening for bladder cancer.

@article{Srivastava2016ClinicalUO,
  title={Clinical utility of urinary soluble Fas in screening for bladder cancer.},
  author={Anupam Kumar Srivastava and Pankaj K Singh and Dhramveer Singh and Diwakar Dalela and Srikanta Kumar Rath and Madan Lal Brahma Bhatt Bhatt},
  journal={Asia-Pacific journal of clinical oncology},
  year={2016},
  volume={12 2},
  pages={e215-21}
}
AIM Early diagnosis of carcinoma of urinary bladder remains a challenge. Urine cytology, as an adjunct to cystoscopy, is less sensitive for low-grade tumors. Soluble Fas (sFas), a cell-surface receptor and member of the tumor necrosis factor superfamily, is frequently expressed in urinary bladder carcinoma. The objective of this study was to investigate the urinary sFas for diagnosis of transitional cell carcinoma (TCC) of urinary bladder. METHODS We examined urinary sFas concentration in 74… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
2 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…